General Neuro Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Crowdfunding
- Latest Deal Amount
-
$21.3K
- Investors
-
3
General Neuro General Information
Description
Developer of non-invasive neurostimulation devices designed to support language learning and rehabilitation of language disorders. The company offers transcranial electrical stimulation headsets, synchronised training software, remote speech-language therapy, and device-guided rehabilitation programs, enabling language learners, stroke survivors, and children with reading disorders to access non-invasive training and rehabilitation.
Contact Information
Website
www.generalneuro.comCorporate Office
- Boston, MA
- United States
Corporate Office
- Boston, MA
- United States
General Neuro Timeline
General Neuro Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Product Crowdfunding | 19-Mar-2026 | $21.3K | Completed | Generating Revenue | ||
| 3. Seed Round | 24-Feb-2026 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 27-May-2025 | $10K | $260K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2025 | $250K | $250K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
General Neuro Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
General Neuro Patents
General Neuro Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260273219-A1 | System and method for enhancing language learning through targeted transcranial electrical stimulation | Pending | 17-Mar-2025 | ||
| WO-2026198589-A1 | System and method for enhancing language learning through targeted transcranial electrical stimulation | Pending | 17-Mar-2025 |
General Neuro Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
General Neuro Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HAX | Corporate Venture Capital | Minority | ||
| SOSV | Venture Capital | Minority | ||
| Tsai CITY | Accelerator/Incubator | Minority |
General Neuro FAQs
-
When was General Neuro founded?
General Neuro was founded in 2024.
-
Where is General Neuro headquartered?
General Neuro is headquartered in Boston, MA.
-
What is the size of General Neuro?
General Neuro has 4 total employees.
-
What industry is General Neuro in?
General Neuro’s primary industry is Therapeutic Devices.
-
Is General Neuro a private or public company?
General Neuro is a Private company.
-
What is General Neuro’s current revenue?
The current revenue for General Neuro is .
-
How much funding has General Neuro raised over time?
General Neuro has raised $260K.
-
Who are General Neuro’s investors?
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
